High vascular endothelial growth factor gene expression predicts poor outcome in patients with non-luminal A breast cancer

• Published in: Molecular and clinical oncology Vol. 3; no. 5; pp. 1103 - 1108
• Main Authors: SA-NGUANRAKSA, DOONYAPAT, CHUANGSUWANICH, TUENJAI, PONGPRUTTIPAN, TAWATCHAI, O-CHAROENRAT, PORNCHAI
• Format: Journal Article
• Language: English
• Published: England D.A. Spandidos 01.09.2015; Spandidos Publications; Spandidos Publications UK Ltd
• Subjects: Age; angiogenesis; Breast cancer; Cancer therapies; Care and treatment; Cloning; Epidermal growth factor; Estrogens; Gene expression; Genetic aspects; growth factor; hormone receptor; Hospitals; human epidermal growth factor receptor 2; Medical prognosis; Metastasis; Multivariate analysis; Oncology; Patients; Physiological aspects; Rodents; Surgery; Vascular endothelial growth factor; Womens health; Thailand; growth factor; breast cancer; human epidermal growth factor receptor 2; hormone receptor; angiogenesis; vascular endothelial growth factor

Breast cancer is the most frequent type of cancer among women worldwide. Vascular endothelial growth factor (VEGF), the key modulator of angiogenesis, has been implicated in breast cancer susceptibility and aggressiveness. VEGF expression was determined in 99 breast cancer tissue samples using rever...